Evidence map›Paper›PMID 41618501›Full record

ArticleChembiochem : a European journal of chemical biology2026

Genetic Encoding of a Trifunctional Photo-Cross-Linker with a Cleavable Alkyl Ester Moiety.

Masahiro Takayama, Tomoya Tsubota, Takao Yamaguchi, Kosuke Chiba, Takumi Yoshida, Yoshiyuki Hari, Yu-Shi Tian, Daisuke Takaya, Asuka Mori, Tomohito Tsukamoto and 9 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Masahiro TakayamaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Tomoya TsubotaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Takao YamaguchiGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0003-3180-0257
Kosuke ChibaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0002-8074-4549
Takumi YoshidaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Yoshiyuki HariFaculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
Yu-Shi TianGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0002-8988-9453
Daisuke TakayaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0001-6020-8151
Asuka MoriGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Tomohito TsukamotoGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Kenji IshimotoGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Yukio AgoGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0001-7562-4000
Yoshiaki OkadaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Kensaku SakamotoLaboratory for Nonnatural Amino Acid Technology, RIKEN Center for Biosystems Dynamics Research, RIKEN, Yokohama, Japan.
Takefumi DoiGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Kaori FukuzawaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0001-5357-8250
Satoshi ObikaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0002-6842-6812
Shinsaku NakagawaGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0001-9500-8889
Nobumasa HinoGraduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.ORCID https://orcid.org/0000-0002-7072-1183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically encoded photo-cross-linkable amino acids (PAAs) are powerful tools for analyzing direct protein-protein interactions (PPIs) in mammalian cells. Cleavable PAAs are particularly useful, enabling covalent capture and subsequent release of interacting partners, which facilitates the characterization of interaction interfaces using mass spectrometry. However, the limited options for cleavable linker structures have restricted the design of PAAs. In this study, we genetically encoded a novel trifunctional PAA, DiZAAsu, which contains three distinct chemical groups: diazirine, alkyne, and alkaline-cleavable alkyl ester moieties. An archaeal pyrrolysyl-tRNA synthetase was engineered to incorporate DiZAAsu efficiently into proteins in mammalian cells. We demonstrated the in-cell photoreactive function of diazirine by cross-linking the DiZAAsu-introduced GRB2 protein to its binding partner, SHC. Using the alkyne group for biotinylation, we established a tandem affinity purification strategy that enabled efficient enrichment of the cross-linked complex, thereby reducing nonspecific protein contamination. The alkaline-based cleavage of the ester group in DiZAAsu was also demonstrated, confirming its potential for the dissociation of covalently linked complexes. This system thus expands the design space of multifunctional PAAs and adds alkaline-based dissociation to the limited repertoire of available cleavage strategies.

Indexed as

Amino AcidsCross-Linking ReagentsEstersGRB2 Adaptor ProteinAlkynesAmino Acyl-tRNA SynthetasesDiazomethaneHEK293 CellsHumansLysinePhotochemical ProcessesAlkynesAmino AcidsAmino Acyl-tRNA SynthetasesCross-Linking ReagentsDiazomethaneEstersGRB2 Adaptor ProteinLysinegenetic code expansionnoncanonical amino acidphoto‐cross‐linkingprotein modificationsprotein‐protein interactions

Identifiers

PMID41618501
PMCPMC12859177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.